Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

A negative covariation between toxoplasmosis and CoVID-19 with alternative interpretations


Coronaviruses may exert severely negative effects on the mortality and morbidity of birds and mammals including humans and domestic animals. Most recently CoVID-19 has killed about half million people (27th of June, 2020). Susceptibility to this disease appears to differ markedly across different societies but the factors underlying this variability are not known. Given that prevalence of toxoplasmosis in human societies may serve as a proxy for hygiene, and it also exerts both direct and immune-mediated antiviral effects, we hypothesize a negative covariation between toxoplasmosis and measures of the CoVID-19 pandemic across countries. We obtained aged-adjusted toxoplasmosis prevalence of pregnant women from the literature. Since the differences in the CoVID-19 morbidity and mortality may depend on the different timing of the epidemics in each country, we applied the date of first documented CoVID-19 in each country as a proxy of susceptibility, with a statistical control for population size effects. Using these two indices, we show a highly significant negative co-variation between the two pandemics across 86 countries. Then, considering that the wealth of nations often co-varies with the prevalence of diseases, we introduced GDP per capita into our model. The prevalence of toxoplasmosis co-varies negatively, while the date of first CoVID-19 co-varies positively with GDP per capita across countries. Further, to control for the strong spatial autocorrelation among countries, we carried out a Spatial Structure Analyses of the relationships between the date of first CoVID-19, prevalence of toxoplasmosis, and GDP per capita. Results of this analysis did not confirm a direct causal relationship between toxoplasmosis and susceptibility to the CoVID-19 pandemics. As far as an analysis of observational data let us to suggest, it appears that the interaction between CoVID-19 and toxoplasmosis is mediated by GDP per capita and spatial effects. This prompts the question whether the formerly known covariations of CoVID-19 and BCG vaccination or air pollution might have also emerged as spurious indirect effects.


Coronaviruses are positive-stranded RNA viruses that may exert severely negative effects on the mortality and morbidity of a broad range of birds and mammals including humans and domestic animals. The strain called SARS-CoV-2 host-switched from bats to humans in Wuhan, China in November 2019 and subsequently gave rise to a devastating global pandemic called CoVID-191,2,3. Susceptibility of human societies appear to be markedly heterogeneous ranging from modest to very high morbidity. Contrary to general expectations, more developed, wealthier communities living under better hygienic conditions appear to be more threatened than others. Thus, Austria is seemingly more severely hit than Hungary, the Czech Republic than Slovakia, and Israel than Palestine or Jordan.

Evidently, the first step to search for factors influencing this pandemic is to identify environmental correlates of different populations’ susceptibility. Sala and Miyakawa4 suggested that the different BCG vaccination policies across countries may partly explain differences in susceptibility to CoVID-19. Indeed, higher morbidity and mortality is observed in societies with no obligatory BCG vaccination. However, vaccination schemes tend to be uniform within countries, thus this hypothesis cannot explain the huge within-country differences that are often observed, such as those between Northern vs. Southern Italy. Zhu et al.5 described a covariation between exposure to air pollution and CoVID-19 infection.

We hypothesize that certain common infections coming together with a less hygienic lifestyle may trigger the human immune system and thus facilitate some protection against CoVID-19, an argument similar to the so-called ‘hygiene hypothesis’6. Toxoplasmosis is a candidate infection for this purpose because of two reasons. First, it is one of the most widespread latent infections of humanity7,8. As it does not transmit from human to human, its prevalence can be interpreted as a generalized index of group hygiene. Second, its causative agent, the eukaryotic protozoan Toxoplasma gondii, is known to exhibit at least some antiviral effects9.

Toxoplasma gondii is an intracellular parasite that infects birds and mammals as intermediate hosts, while the sexual phase of its life cycle can only be completed in feline definitive hosts, most often in domestic cats. It is distributed in human societies mostly by semi-domestic, partly-feral cats that depredate on infected rodents and birds and then eat their prey. Subsequently, the infective spores are released through their faeces and may get into direct contact with humans to cause infections. Alternatively, domestic animals may be infected by these spores and the consumption of their infected meat transmits T. gondii to humans. Thus, humans act like intermediate hosts, although they are not depredated by cats, and thus this is a dead-end for the parasites. ‘Luxury cats’ living on canned pet-food throughout their life may not transmit this infection. Asymptomatic infections are common in humans, especially among those living in the proximity of semi-feral domestic cats10.

Toxoplasma gondii excretes Dense Granule Protein-7 (GRA-7) into the host cell that inhibits viral replication. Its effect has been proven both in vitro and in vivo against indiana vesiculovirus, influenza A virus, Coxsackie virus, and herpes simplex virus. Overall, GRA-7 exhibits immune-stimulatory and a broad spectrum of antiviral activities via type I interferons signaling9. Moreover, in response to T. gondii infection, laboratory mice highly upregulate Immune Responsive Gene 1 in their lungs11. This is an interferon-stimulated gene that mediates antiviral effects against RNA viruses like the West Nile and Zika viruses through its product named itaconate12. It has been established that GRA-7 could be serve as alternative to treat tuberculosis13.

We need to emphasize, however, that the antiviral activities of Toxoplasma gondii are limited to the first, short and virulent phase of the infection, and not known to operate through the subsequent latent period that may last through the whole life of the host. Therefore, even in societies where a large proportion of the population carries latent toxoplasmosis, the proportion of infections actually expressing antiviral activities is very low. Thus we only claim that Toxoplasma gondii expresses at least some antiviral adaptations. Moreover, the apicoplast proteins of Toxoplasma are known to have immunogenic potential14.

Finally, we chose toxoplasmosis out of the candidate human infections partly because the availability of prevalence data from as many countries as possible. Unfortunately, as in the case of all other human infections, the methodologies of gathering and evaluating epidemiological data can be quite heterogeneous across countries. Below we set out to test whether there is a negative co-variation between levels of toxoplasmosis and CoVID-19 pandemic at a global scale.


The linear regression model without a spatial component (Table 1, model 1, Fig. 1B,C) indicates that toxoplasmosis (N = 86; Fig. 2) is positively related to CoVID-19 Delay (Fig. 3), while GDP per capita (Fig. 4) is negatively related to CoVID-19 Delay. The total variation explained by these environmental variables is 36.8%.

Table 1 Linear regression models explaining CoVID-19 delay in different countries and due to toxoplasmosis and Gross Domestic Product (GDP) per capita.
Figure 1

Linear regressions. (A) Starting date of epidemic counted since first case in China26 with relationship to population size of each country25. Residuals are used in (B) and (C) as dependent variable (CoVID-19 Delay). (B) CoVID-19 Delay in days (negative values = CoVID-19 faster, positive values = CoVID-19 later) and Toxoplasma prevalence. (C) CoVID-19 Delay and Gross Domestic Product per capita (GDP).

Figure 2

Spatial distribution of adjusted Toxoplasma prevalence23. China was not included in analysis because it was treated as 1st day case. The map was generated in QGIS software version 3.8.3-Zanzibar (

Figure 3

Spatial distribution of CoVID-19 Delay (negative values = CoVID-19 faster, positive values = CoVID-19 later). China was not included in the analysis because it was treated as 1st day case. The map was generated in QGIS software version 3.8.3-Zanzibar (

Results of the linear model with spatial covariates are presented in Table 1, model 2. Akaike information criterion indicates a better fit of this model. Total variation of all environmental variables plus the spatial variable is 52.3%. Variance partitioning indicates that the total variation explained by GDP per capita is 31.0%, by toxoplasmosis prevalence is 23.6%, and by the spatial component it is 39.5%. However, variation explained only by the spatial competent was 18.9%, only by GDP per capita was 10.8% (with the spatial component it was 13.2%) and by toxoplasmosis only it was 0.08% (with spatial component 5.9%).


As we predicted, there was a negative correlation between the prevalence of toxoplasmosis and the start CoVID-19 pandemics across countries that would be considered ‘highly significant’ by conventional measures. Moreover, as it is the case with many other diseases15, GDP per capita values co-vary negatively with toxoplasmosis prevalence. Opposite to this pattern, however, CoVID-19 emerged earlier in wealthier societies, most probably due to their more intensive participation of the global tourism and traffic industries.

Introducing a spatial component into the analysis, however, modified this result. It appears that CoVID-19 delay is greatly influenced by GDP per capita and spatial position of each country, while the effect of toxoplasmosis—contrary to our expectation—is weaker. This indicates that the strong negative covariation we have documented between prevalence of toxoplasmosis and the emergence of CoVID-19 on a global scale is likely to be a spurious side-effect mediated by GDP per capita and spatial effects. Perhaps the pathogen species, Toxoplasma gondii, we have chosen to investigate, or our methodologies, or the types of rough data we have analyzed were insufficient to verify it, or this interaction does not exist at all.

On the other hand, the above results does not falsify the hypothesis that CoVID-19 interacts negatively with other pathogens. The prevalence of toxoplasmosis may act as a proxy measure of group hygiene and our results may indicate a negative interaction of CoVID-19 with other, yet unidentified pathogens that are more widespread in resource-poor countries16.

Coronaviruses surround us, and we most probably get into unnoticed and symptomless contacts with human coronaviruses like HCoV-OC43 and HCoV-229E, and porcine and feline coronaviruses (PEDV, FCoV) quite frequently. We do not exclude the scenario that the variability in human populations’ resistance vs. susceptibility to the current CoVID-19 pandemic is influenced by such widespread but asymptomatic pathogens. Accordingly, a recent study indicated cross-reactivity with circulating common coronaviruses causing common cold17. Further, after the decline of the current CoVID-19 pandemic, more reliable indicators of population resistance vs. susceptibility will be available for our purposes, like the morbidity or mortality rates.

Our results may also serve as a cautionary note regarding the apparent interaction of other latent variables and the CoVID-19 pandemics. To date researchers found covariations of this pandemic with schemes of BCG vaccination4,18, vitamin D19, and levels of air pollution20. Although statistically highly significant, most of such studies were not controlled for GDP per capita effects, neither for geographical context4. Thus we cannot exclude the possibility that the apparent influence of BCG vaccination and air pollution on the current coronavirus pandemic is a spurious indirect effect, just as in our case with toxoplasmosis.

Different pathogen species utilizing the same host population as a shared resource tend to form an interactive pathogen community. Within this community, the ecological network of immune-mediated pathogen-pathogen interactions may define the emergence of disease21. How SARS-CoV-2 will be positioned in the global ecological network of human pathogens (probably the most species-rich pathogen community on Earth22) is yet to be seen.


Toxoplasmosis is routinely screened in pregnant women in several countries, thus nation-level prevalence values are available from the literature. We obtained data from Flegr and Dama23 (Fig. 2). Since the prevalence of this parasite is known to be age-dependent, these values were adjusted to a standard age following Lafferty24.

Currently, the CoVID-19 pandemic is still in its growing phase in many countries, but possibly saturated or already declining in others. Thus the actual measures of morbidity or mortality would be misleading to compare among countries. Therefore, we compared the starting date, i.e. the date of the first documented case of the CoVID-19 disease in each country. For obvious reasons, countries with large population sizes are more likely to have earlier dates of the first case of the disease. To control for population size differences, we applied residuals taken from the (first date ~ log [population size]) regression (Fig. 1A; β0 = 178.241 ± 18.258 s.e, βlog(population) = − 10.673 ± 2.527 s.e., t value = − 4.223, P < 0.001). Positive residuals mean that countries had later start of the pandemic as expected (more resistant), while negative residuals indicate that countries had earlier starting dates (more susceptible). This variable is interpreted as a population-size-corrected time delay of first documented case of CoVID-19 in each country, and hereafter we called it ‘CoVID-19 Delay’ (Fig. 3). Population sizes of each country were taken from UNData25, with values of countries that recently split treated accordingly. The first date of disease from CoVID-19 in each country originated from WHO26.

The prevalence of numerous human diseases depends on GDP per capita as an estimate of resource availability, and hence the ability to live a healthy life without exposure to zoonoses, and/or in the absence of untreated diseases27. To control for this, both in the case of toxoplasmosis and CoVID-19, we introduced Gross Domestic Product (GDP 2018) per capita (Fig. 4), derived from World Bank data28.

Figure 4

Spatial distribution of Gross Domestic Product (GDP)28 per capita. China not included in the analysis because it was treated as 1st day case. The map was generated in QGIS software version 3.8.3-Zanzibar (

Further, statistical autocorrelation is a general feature of ecological variables measured across geographic space29. Since this effect, called spatial autocorrelation, violates the assumption of the independence of data required by most standard statistical procedures, we applied a Spatial Structure Analyses of the relationships between the date of first CoVID-19 documented case (controlled for human population size), prevalence of toxoplasmosis (age adjusted), and GDP per capita.

Using a linear regression model, we analyzed the relationship between these three variables. We found no issue with multicollinearity between toxoplasmosis prevalence and GDP per capita (VIF = 1.325). However, there was negative spatial correlation (Pearson’s r = − 0.495, Corrected Pearson’s r F = 14.598, Corrected D.F. = 44.921, p < 0.001; Figs. 2 and 4) between these two variables.

We tested all used variables for spatial autocorrelation with Moran’s local indicator (Moran’s I)29. Indices > 0 indicate that pairs of locations are more similar, those < 0 indicate pairs that are less similar than expected by random pairs of observations. Moran’s Is were computed for 11 distance classes and were showed on spatial correlograms. Analyzes of these correlograms indicate (Supplementary Information 1) significant spatial similarity of neighboring countries according to toxoplasmosis prevalence, CoVID-19 Delay and GDP per capita (Figs. 2, 3, 4). In order to account for spatial autocorrelation, we used spatial eigenvector mapping (SEVM)30. This tool allows us to select an eigenvector (spatial filters) that minimalizes Moran’s I in model residuals. Then selected filters can be used as explanatory variables in the linear model. We used partial regression analyses to quantify how much of the variation of the response variable is explained by the spatial structure versus by the environmental variables.

All analyses were computed using SAM software30. Regression graphs were plotted using ggplot2 package31 in R statistical software32. Maps were created using QGIS software (version 3.8.3-Zanzibar)33.


  1. 1.

    Hui, D. S. et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—The latest 2019 novel coronavirus outbreak in Wuhan, China. Int. J. Infect. Dis. 91, 264–266 (2020).

    CAS  Article  Google Scholar 

  2. 2.

    El Zowalaty, M. E. & Järhult, J. D. From SARS to COVID-19: A previously unknown SARS-related coronavirus (SARS-CoV-2) of pandemic potential infecting humans—Call for a One Health approach. One Health. 9, 100124. (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  3. 3.

    Marty, A. M. & Jones, M. K. The novel coronavirus (SARS-CoV-2) is a one health issue. One Health. 9, 100123. (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  4. 4.

    Sala, G. & Miyakawa, T. Association of BCG vaccination policy with prevalence and mortality of COVID-19. Medrxiv (2020).

    Article  Google Scholar 

  5. 5.

    Zhu, Y., Xie, J., Huang, F. & Cao, L. Association between short-term exposure to air pollution and COVID-19 infection: Evidence from China. Sci. Total Environ. 727, 138704. (2020).

    ADS  CAS  Article  PubMed  PubMed Central  Google Scholar 

  6. 6.

    Yazdanbakhsh, M., Kremsner, P. G. & Van Ree, R. Allergy, parasites and the hygiene hypothesis. Science 296, 490–494 (2002).

    ADS  CAS  Article  Google Scholar 

  7. 7.

    Flegr, J. How and why toxoplasma makes us crazy. Trends Parasitol. 29, 156–163 (2013).

    Article  Google Scholar 

  8. 8.

    Fekadu, A., Shibre, T. & Cleare, A. J. Toxoplasmosis as a cause for behaviour disorders—Overview of evidence and mechanisms. Folia Parasitol. 57, 105–113 (2010).

    Article  Google Scholar 

  9. 9.

    Weeratunga, P. et al. Dense Granule Protein-7 (GRA-7) of Toxoplasma gondii inhibits viral replication in vitro and in vivo. J. Microbiol. 55, 909–917 (2017).

    CAS  Article  Google Scholar 

  10. 10.

    Dubey, J. P. General Biology. Toxoplasmosis of Animals and Humans (Taylor and Francis Group, Abingdon, 2010).

    Google Scholar 

  11. 11.

    Degrandi, D., Hoffmann, R., Beuter-Gunia, C. & Pfeffer, K. The proinflammatory cytokine-induced IRG1 protein associates with mitochondria. J. Interferon. Cytokine Res. 29, 55–67 (2009).

    CAS  Article  Google Scholar 

  12. 12.

    Daniels, B. P. et al. The nucleotide sensor ZBP1 and kinase RIPK3 induce the enzyme IRG1 to promote an antiviral metabolic state in neurons. Immunity 50, 64–76 (2019).

    CAS  Article  Google Scholar 

  13. 13.

    Kim, Y. R. & Yang, C. S. Host-directed therapeutics as a novel approach for tuberculosis treatment. J. Microbiol. Biotechnol. 27, 1549–1558 (2017).

    CAS  Article  Google Scholar 

  14. 14.

    Can, H., Erkunt Alak, S., Köseoğlu, A. E., Döşkaya, M. & Ün, C. Do Toxoplasma gondii apicoplast proteins have antigenic potential? An in silico study. Comput. Biol. Chem. 84, 107158. (2020).

    CAS  Article  PubMed  Google Scholar 

  15. 15.

    Dieleman, J. L. et al. Trends in future health financing and coverage: Future health spending and universal health coverage in 188 countries, 2016–40. Lancet 391, 1783–1798 (2018).

    Article  Google Scholar 

  16. 16.

    Njenga, M. K. et al. Why is there low morbidity and mortality of COVID-19 in Africa?. Am. J. Trop. Med. Hyg. (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  17. 17.

    Grifoni, A. et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 181, 1–13 (2020).

    Article  Google Scholar 

  18. 18.

    Netea, M. G. et al. Trained immunity: A tool for reducing susceptibility to and the severity of SARS-CoV-2 infection. Cell 181, 969–977 (2020).

    CAS  Article  Google Scholar 

  19. 19.

    Grant, W. B. et al. Evidence that vitamin D supplementation could reduce risk of influenza and covid-19 infections and deaths. Nutrients 12, 1–19 (2020).

    Google Scholar 

  20. 20.

    Wu, X., Nethery, R. C., Sabath, M. B., Braun, D. & Dominici, F. Exposure to air pollution and COVID-19 mortality in the United States: A nationwide cross-sectional study. MedRxiv (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  21. 21.

    Telfer, S. et al. Species interactions in a parasite community drive infection risk in a wildlife population. Science 330, 243–246 (2010).

    ADS  CAS  Article  Google Scholar 

  22. 22.

    Dunn, R. R., Davies, T. J., Harris, N. C. & Gavin, M. C. Global drivers of human pathogen richness and prevalence. Proc. R. Soc. B Biol. Sci. 277, 2587–2595 (2010).

    Article  Google Scholar 

  23. 23.

    Flegr, J. & Dama, M. Does the prevalence of latent toxoplasmosis and frequency of Rhesus-negative subjects correlate with the nationwide rate of traffic accidents?. Folia Parasitol. 61, 485–494 (2014).

    CAS  Article  Google Scholar 

  24. 24.

    Lafferty, K. D. Can the common brain parasite, Toxoplasma gondii, influence human culture?. Proc. R. Soc. B Biol. Sci. 273, 2749–2755 (2006).

    Article  Google Scholar 

  25. 25.

    UNdata. United Nations Statistics Division 2019. Total population, both sexes combined (thousands). (2019).,4,6,7&s=_crEngNameOrderBy:asc,_timeEngNameOrderBy:desc,_varEngNameOrderBy:asc&v=1. (Accessed: 17th June 2019)

  26. 26.

    WHO. Coronavirus (COVID-19). (2020). (Accessed: 10th April 2020)

  27. 27.

    Janssens, J.-P. & Rieder, H. L. An ecological analysis of incidence of tuberculosis and per capita gross domestic product. Eur. Respir. J. 32, 1415–1416 (2008).

    Article  Google Scholar 

  28. 28.

    World Bank. GDP (current US$). (2020). (Accessed: 16th April 2020)

  29. 29.

    Legendre, P. Spatial autocorrelation: Trouble or new paradigm?. America. 74, 1659–1673 (1993).

    Google Scholar 

  30. 30.

    Rangel, T. F., Diniz-Filho, J. A. F. & Bini, L. M. SAM: A comprehensive application for spatial analysis in macroecology. Ecography 33, 46–50 (2010).

    Article  Google Scholar 

  31. 31.

    Wickham, H. ggplot2: Elegant Graphics for Data Analysis (Springer, Berlin, 2016).

    Book  Google Scholar 

  32. 32.

    R Development Core Team. R: A language and environment for statistical computing. (2018).

  33. 33. QGIS Geographic Information System Open Source Geospatial Foundation Project. (2020).

Download references


LR was supported by the grant “In the light of evolution: theories and solutions” (GINOP-2.3.2-15-2016-00057). PT was supported by the statutory funding (FVS PULS 506-511-05).

Author information




Ł.J. methodology, software, visualization, formal analysis; L.R. conceptualization, writing—original draft, P.T. conceptualization; writing-reviewing and editing; A.P.M. conceptualization, supervision.

Corresponding author

Correspondence to Łukasz Jankowiak.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Jankowiak, Ł., Rozsa, L., Tryjanowski, P. et al. A negative covariation between toxoplasmosis and CoVID-19 with alternative interpretations. Sci Rep 10, 12512 (2020).

Download citation


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing